Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 4, 2007, Pages 221-228

  Bekris, L M ^a   Shephard, C ^a   Janer, M ^c   Graham, J ^b   McNeney, B ^b   Shin, J ^b   Zarghami, M ^a   Griffith, W ^a   Farin, F ^a   Kavanagh, T J ^a   Lernmark, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SIMON FRASER UNIVERSITY   (Canada)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

GCLC; Glutathione; Promoter polymorphisms; Type 1 diabetes

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CATALYST; CHILD; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; GLUTAMATE DECARBOXYLASE; GLUTAMATE-CYSTEINE LIGASE; HUMANS; INFANT; ISOENZYMES; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 34248569588     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970574     Document Type: Article

References (66)

1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221-9
2. Badenhoop K, Boehm BO. Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease. Exp Clin Endocrinol Diabetes. 2004; 112: 407-415
3. Bastar I, Seckin S, Uysal M, Aykac-Toker G. Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Commun Mol Pathol Pharmacol 1998; 102: 265-272
4. Bea F, Hudson FN, Chait A, Kavanagh TJ, Rosenfeld ME. Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements. Circ Res 2003; 92: 386-393 Epub 2003 Feb 6.
5. Bekris LM, Viernes HM, Farin FM, Maier LA, Kavanagh TJ, Takaro TK. Chronic beryllium disease and glutathione biosynthesis genes. J Occup Environ Med. 2006; 48: 599-606
6. Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, Barnett AH, Bain SC, Todd JA. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: Dominant protection and parental transmission of allele of the insulin gene-linked minisatellite locus. J. Autoimmunity 1996; 9: 415-421
7. Beutler E, Gelbart T, Kondo T, Matsunaga AT. The molecular basis of a case of gamma-glutamylcysteine synthetase deficiency. Blood 1999; 94: 2890-2894
8. Blohmé G, Nyström L, Arnqvist HJ, Lithner F, Littorin B, Olsson PO, Scherstén B, Wibell L, Ostman J. Male predominance of Type 1 (insulin-dependent) diabetes mellitus in young adult: results from a 5-year prospective nationwide study of the 15-34 year age group in Sweden. Diabetologia 1992; 35: 55-62
9. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF. Quantification of islet cell antibodies and prediction of insulin dependent diabetes. Lancet 1990; 335: 147-149
10. Bonifacio E, Lernmark A, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 1988; 106: 83-88
11. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet. 2004; 36: 337-338 Epub 2004 Mar 7.
12. Bottino R, Balamurugan AN, Tse H, Thirunavukkarasu C, Ge X, Profozich J, Milton M, Ziegenfuss A, Trucco M, Piganelli JD. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53: 2559-2568
13. Comhair SA, Lewis MJ, Bhathena PR, Hammel JP, Erzurum SC. Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med. 1999; 159: 1824-1829
14. Dickinson DA, Levonen AL, Moellering DR, Arnold EK, Zhang H, Darley-Usmar VM, Forman HJ. Human glutamate cysteine ligase gene regulation through the electrophile response element. Free Radic Biol Med 2004; 37: 1152-1159
15. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998; 21: 1736-1742
16. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, Lernmark Å. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113-125
17. Gale EA, Gillespie KM. Diabetes and gender. Diabetologia 2001; 44: 3-15
18. Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Pietropaolo M, Eisenbarth GE. ICA512 autoantibody radioassay. Diabetes 1995; 44: 1340-1344
19. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51: 1346-1355
20. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes - Follow-up of the Seattle Family Study. Diabetes 1999; 48: 170-175
21. Griffith OW, Mulcahy RT. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv Enzymol Relat Areas Mol Biol 1999; 73: 209-267 , xii.
22. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-350
23. Hamilton D, Wu JH, Alaoui-Jamali M, Batist G. A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production. Blood 2003; 102: 725-730 . Epub 2003 Mar 27.
24. Hegewald M, Schoenfeld S, McCulloch D, Greenbaum C, Klaff LJ, Palmer JP. Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type 1 diabetes. J Immunol Methods 1992; 154: 61-68
25. Ho E, Bray TM. Antioxidants, NFkappaB activation, and diabetogenesis. Proc Soc Exp Biol Med 1999; 222: 205-213
26. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehjto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 1516-1526
27. Kim SK, Woodcraft KJ, Khodadadeh SS, Novak RF. Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 2004; 311: 99-108 . Epub 2004 May 28.
28. Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, Yoshimura M, Ogawa H. Association of polymorphism in glutamatecysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol 2003; 41: 539-545
29. Kondo H, Mori S, Takino H, Kijima H, Yamasaki H, Ozaki M, Tetsuya I, Urata Y, Abe T, Sera Y, Yamakawa K, Kawasaki E, Yamaguchi Y, Kondo T, Eguchi K. Attenuation of expression of gamma-glutamylcysteine synthetase by ribozyme transaction enhance insulin secretion by pancreatic beta cell line, MIN6. Biochem Biophys Res Commun 2000; 278: 236-240
30. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun 2000; 1: 170-184
31. Krzywanski DM, Dickinson DA, Iles KE, Wigley AF, Franklin CC, Liu RM, Kavanagh TJ, Forman HJ. Variable regulation of glutamate cysteine ligase subunit proteins affects glutathione biosynthesis in response to oxidative stress. Arch Biochem Biophys 2004; 423: 116-125
32. LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, Nepom GT, McCulloch DK, Hagopian WA. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002; 25: 505-511
33. Landin-Olsson M, Karlsson FA, Lernmark Å, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15-34 years old patients in the Diabetes Incidence Study in Sweden (DISS). Diabetes 1992a; 41: 1022-1027
34. Landin-Olsson M, Palmer JP, Lernmark AÅA, Blom L, Sundkvist G, Nystrom L, Dahlquist G. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992b; 35: 1068-1073
35. Lowe RM, Graham J, Sund G, Kockum I, Landin-Obson M, Schaefer JB, Torn C, Lernmark A, Dahlquist G. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes. Autoimmunity 2000; 32: 173-180
36. Manna SK, Kuo MT, Aggarwal BB. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene 1999; 18: 4371-4382
37. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563-1574
38. Mathis D, Vence L, Benoist C. beta-Cell death during progression to diabetes. Nature 2001; 414: 792-798
39. McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farin FM, Tonelli MR, Pare PD, Sandford AJ, Aitken ML, Kavanagh TJ. Variants in the Glutamate-Cysteine-Ligase Gene are Associated with Cystic Fibrosis Lung Disease. Am J Respir Crit Care Med 2006; 11: 11
40. Morrice NA, Powis SJ. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol 1998; 8: 713-716
41. Mulcahy RT, Gipp JJ. Identification of a putative antioxidant response element in the 5′-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Biophys Res Commun 1995; 209: 227-233
42. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001; 108: 1247-1252
43. Oda T, Sadakata N, Komatsu N, Muramatsu T. Specific efflux of glutathione from the basolateral membrane domain in polarized MDCK cells during ricin-induced apoptosis. J Biochem (Tokyo) 1999; 126: 715-721
44. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002; 3: 235-249
45. Pugliese A, Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev 2002; 18: 13-25
46. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992; 41: 183-186
47. Rabinovitch A. Free radicals as mediators of pancreatic islet beta-cell injury in autoimmune diabetes. J Lab Clin Med 1992; 119: 455-456
48. Rasilainen S, Nieminen JM, Levonen AL, Otonkoski T, Lapatto R. Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide. Biochem Pharmacol 2002; 63: 1297-1304
49. Ristoff E, Augustson C, Geissler J, de Rijk T, Carlsson K, Luo JL, Andersson K, Weening RS, van Zwieten R, Larsson A, Roos D. A missense mutation in the heavy subunit of gamma-glutamylcysteine synthetase gene causes hemolytic anemia. Blood 2000; 95: 2193-2196
50. Rocic B, Vucic M, Knezevic-Cuca J, Radica A, Pavlic-Renar I, Profozic V, Metelko Z. Total plasma antioxidants in first-degree relatives of patients with insulin-dependent diabetes. Exp Clin Endocrinol Diabetes 1997; 105: 213-217
51. Sanjeevi CB, Höök P, Landin-Olsson M, Kockum I, Dahlquist G, Lybrand TP, Lernmark Å. DR4 subtypes and their molecular properties in a population base study of Swedish childhood diabetes. Tissue Antigens 1996; 47: 275-283
52. Seghrouchni I, Drai J, Bannier E, Riviere J, Calmard P, Garcia I, Orgiazzi J, Revol A. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 2002; 321: 89-96
53. Short S, Merkel BJ, Caffrey R, McCoy KL. Defective antigen processing correlates with a low level of intracellular glutathione. Eur J Immunol 1996; 26: 3015-3020
54. Siitonen T, Alaruikka P, Mantymaa P, Savolainen ER, Kavanagh TJ, Krejsa CM, Franklin CC, Kinnula V, Koistinen P. Protection of acute myeloblasts leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress. Ann Oncol 1999; 10: 1361-1367
55. Telci A, Cakatay U, Salman S, Satman I, Sivas A. Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res Clin Pract 2000; 50: 213-223
56. Tiedge M, Lortz S, Munday R, Lenzen S. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 1998; 47: 1578-1585
57. Tiedge M, Lortz S, Munday R, Lenzen S. Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 1999; 42: 849-855
58. Tran PO, Parker SM, LeRoy E, Franklin CC, Kavanagh TJ, Zhang T, Zhou H, Vliet P, Oseid E, Harmon JS, Robertson RP. Adenoviral overexpression of the glutamylcysteine ligase catalytic subunit protects pancreatic islets against oxidative stress. J Biol Chem 2004; 279: 53988-53993 . Epub 2004 Oct 12.
59. Tsuchiya K, Mulcahy RT, Reid LL, Disteche CM, Kavanagh TJ. Mapping of the glutamate-cysteine ligase catalytic subunit gene (GLCLC) to human chromosome 6p12 and mouse chromosome 9D-E and of the regulatory subunit gene (GLCLR) to human chromosome 1p21-p22 and mouse chromosome 3H1-3. Genomics 1995; 30: 630-632
60. van den Dobbelsteen DJ, Nobel CS, Schlegel J, Cotgreave IA, Orrenius S, Slater AF. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J Biol Chem 1996; 271: 15420-15427
61. Varvarovska J, Racek J, Stozicky F, Soucek J, Trefil L, Pomahacova R. Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives. J Diabetes Complications 2003; 17: 7-10
62. Verge CF, Gianani R, Yu L, Pietropaolo M, Smith T, Jackson RA, Soeldner JS, Eisenbarth GS. Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type 1 diabetes. Diabetes 1995; 44: 1176-1179
63. Walsh AC, Feulner JA, Reilly A. Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: association with glutathione levels and drug resistance in the National Cancer Institute tumor cell line panel. Toxicol Sci 2001; 61: 218-223
64. Walsh AC, Li W, Rosen DR. Lawrence DA. Genetic mapping of GLCLC, the human gene encoding the catalytic subunit of gamma-glutamylcysteine synthetase, to chromosome band 6p12 and characterization of a polymorphic trinucleotide repeat within its 5′ untranslated region. Cytogenet Cell Genet 1996; 75: 14-16
65. Weets I, Kaufman L, Van Der Auwera B, Crenier L, Rooman RP, De Block C, Casteels K, Weber E, Coeckelberghs M, Laron Z, Pipeleers DG, Gorus FK. Seasonality in clinical onset of Type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia 2004; 26: 26
66. Weets I, Van Autreve J, Van der Auwera BJ, Schuit FC, Du Caju MV, Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Dorchy H, Quartier E, Gorus FK. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index. Diabetologia 2001; 44: 40-47